Denis Ardid
Overview
Explore the profile of Denis Ardid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1041
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasteurized improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice
Meynier M, Daugey V, Mallaret G, Gervason S, Meleine M, Barbier J, et al.
Gut Microbes
. 2024 Jan;
16(1):2298026.
PMID: 38170633
Gut - brain communications disorders in irritable bowel syndrome (IBS) are associated with intestinal microbiota composition, increased gut permeability, and psychosocial disturbances. Symptoms of IBS are difficult to medicate, and...
2.
Gervason S, Meleine M, Lolignier S, Meynier M, Daugey V, Birer A, et al.
Pain
. 2023 Sep;
165(5):e39-e54.
PMID: 37756665
The potential role of gut microbiota in pain modulation is arousing an emerging interest since recent years. This study investigated neuromodulatory properties of gut microbiota to identify next-generation probiotics to...
3.
Mallaret G, Lashermes A, Meleine M, Boudieu L, Barbier J, Aissouni Y, et al.
World J Gastroenterol
. 2022 Sep;
28(29):3903-3916.
PMID: 36157543
Background: Chronic abdominal pain is the most common cause for gastroenterology consultation and is frequently associated with functional gastrointestinal disorders including irritable bowel syndrome and inflammatory bowel disease. These disorders...
4.
Meynier M, Baudu E, Rolhion N, Defaye M, Straube M, Daugey V, et al.
Gut Microbes
. 2022 Jan;
14(1):2022997.
PMID: 35090380
Alterations in brain/gut/microbiota axis are linked to Irritable Bowel Syndrome (IBS) physiopathology. Upon gastrointestinal infection, chronic abdominal pain and anxio-depressive comorbidities may persist despite pathogen clearance leading to Post-Infectious IBS...
5.
Delay L, Barbier J, Aissouni Y, Jurczak A, Boudieu L, Briat A, et al.
Pain
. 2021 Sep;
163(7):e837-e849.
PMID: 34561389
Rheumatoid arthritis is frequently associated with chronic pain that still remains difficult to treat. Targeting nerve growth factor (NGF) seems very effective to reduce pain in at least osteoarthritis and...
6.
Delorme J, Bertin C, Delage N, Eschalier A, Ardid D, Authier N, et al.
Pain
. 2020 Jul;
162(1):195-202.
PMID: 32701648
Few studies all based on classical surveys have provided prevalence estimates of chronic pain (CP) in opioid-maintained patients (OMPs) but often had a limited patient sample size and a great...
7.
Defaye M, Nourrisson C, Baudu E, Lashermes A, Meynier M, Meleine M, et al.
Sci Rep
. 2020 Jun;
10(1):9146.
PMID: 32499543
Background: Infectious gastroenteritis is a risk factor for the development of post-infectious Irritable Bowel Syndrome (PI-IBS). Recent clinical studies reported a higher prevalence of the intestinal parasite Blastocystis in IBS...
8.
Chaumette T, Delay L, Barbier J, Boudieu L, Aissouni Y, Meleine M, et al.
Pain
. 2020 Jan;
161(5):1109-1123.
PMID: 31977937
Mechanical allodynia is a cardinal sign of several inflammatory pain disorders where nerve growth factor, a prototypic neurotrophin, plays a crucial role by binding to TrkA receptors. Here, we took...
9.
Defaye M, Gervason S, Altier C, Berthon J, Ardid D, Filaire E, et al.
J Neural Transm (Vienna)
. 2019 Sep;
127(4):445-465.
PMID: 31552496
Among the various regulators of the nervous system, the gut microbiota has been recently described to have the potential to modulate neuronal cells activation. While bacteria-derived products can induce aversive...
10.
Bertin C, Delorme J, Riquelme M, Peyriere H, Brousse G, Eschalier A, et al.
Br J Clin Pharmacol
. 2019 Aug;
86(12):2338-2348.
PMID: 31389036
Aims: Several addictovigilance studies have described the off-label use of morphine sulfate (MS) for nonchronic pain in opioid use disorder (OUD) patients as an alternative to conventional opioid substitution treatments...